Science in Sport (AIM:SIS) share news, analysis and insight

Make your money go further for just 25p per day

Science in Sport (SIS)

Market: AIM · Sector: Food & Drug Retailers

Podcasts

Episode 26 of the Investor’s Champion Podcast

13/07/2024

Outstanding growth from the travel sector

More on Science in Sport

Company Insights

Fund raise | Excellent offering | Renewed focus

09/07/2024

Renewed focus brings improving returns

Company Insights

Delightful results and special dividend | Bonkers Bargain impresses

28/06/2024

An elderly distributor shows the way with yet another special dividend

Podcasts

Episode 8 of the Investor’s Champion Podcast

10/03/2024

The weekly round-up of stock market news including Greggs, Nichols, the British ISA and more

Company Insights

The penny drops | Cash delights | Another AIM takeover

08/03/2024

We are staggered it’s taken so long for a change of approach

Company Insights

Big acquisition premium | Agricultural challenges | Suspensions

04/07/2023

Small margins,, but this business does alright

Company Insights

Lacking detail | Profit warning | Modest value

22/02/2023

One of AIM’s larger companies disappoints - buyers might be circling

Company Insights

Horrendous updates

30/09/2022

Poor results and questionable business models

Company Insights

Atlantis rises from the depths

08/07/2022

Renewable energy group gets a government boost

Company Insights

Moving parts | Trading ahead | Mounting losses

30/03/2022

A mixed bag of results and updates and a new innovator

Company Insights

Not the best, but hardly the worst either

20/01/2022

A previous favourite of private investors is testing their patience

Company Insights

Priced to perfection?

15/09/2021

Results from the very highly rated

Company Insights

Is Science in Sport good value at last? (Updated)

17/03/2021

The pandemic appears to have brought out the best in this company

Company Insights

Blue Prism tumbles but others impress

14/01/2021

A much-hyped business leaves plenty of questions unanswered

Company Insights

Big investment potential from neuroscience

02/12/2020

An exciting company here is powering important trials in neuroscience

Company Insights

Vaccine countdown update: 19 Nov - some awful results here, but promise nonetheless

19/11/2020

Probably some of the worst results we have seen, but…

Company Insights

Coronavirus impact: 16 Sept - keep an eagle eye on this

16/09/2020

This digital marketing platform is starting to deliver

Company Insights

Coronavirus impact: 9 July - another fuel cell group powers past £1billion

09/07/2020

Hydrogen fuel cells continue to be in hot stock market demand

Company Insights

Coronavirus impact: 25 June - cycling is having a great lockdown as this company demonstrates

25/06/2020

Cycling has been enjoying a boom over the lockdown and the UK listed group covered here has been doing nicely as a result

Company Insights

Coronavirus impact: 23 April - wonderful timing leaves this business awash with cash

23/04/2020

News of more fund raises, a few dividend commitments and completion of a deal which puts one company in a very strong position

Company Insights

Stock Market hype: perfectly illustrated by Science in Sport

16/11/2018

The sports nutrition company’s latest acquisition is either a damning indictment of the folly of its stock market valuation or a bargain purchase from a usually canny Walgreen Boots Alliance…

ABOUT INVESTORS CHAMPION

Investor's Champion offers objective, incisive and forthright comment on quoted companies and personal finance. Our content addresses what we believe are the key issues in helping make your money go further.

Investor's Champion is a registered trade mark of Investors Champion Ltd. Investor's Champion Limited is a company registered in England and Wales under number 03577867 whose registered office is at c/o Cox Costello & Horne, Batchworth Lock House, 99 Church Street, Rickmansworth, WD3 1JJ.

All rights reserved. © 2007 - 2024